Market Research Logo

Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review

Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a research-based pharmaceutical company, which carries out the discovery, production and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer’s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others. Ono Pharmaceutical also has many other products in pipeline development. The company offers products in various formulations such as capsules, tablets, injections, patches, dry syrup and intravenous infusion. It has operational presence in Japan, Taiwan, South Korea, the UK and the US. Ono Pharmaceutical is headquartered in Chuo-ku, Osaka, Japan.

Ono Pharmaceutical Co Ltd Key Recent Developments

Dec 21,2016: ONO PHARMACEUTICAL: Revisions of Consolidated Financial Forecasts
Oct 19,2016: Merus Receives Milestone Payment from Ono Pharmaceutical for Selection of Bispecific Antibody Candidate for Clinical Development and Extends Partnership with CMC Service Agreement
Jul 27,2016: Infusion of Nearly $35.4 Million in Grant Funding to Support Roswell Park Research
Mar 01,2016: Completion of the new Research Building (The Third Building) in the Minase Research Institute
Jan 26,2016: ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Ono Pharmaceutical Co Ltd - Key Facts 5
Ono Pharmaceutical Co Ltd - Key Employees 6
Ono Pharmaceutical Co Ltd - Key Employee Biographies 7
Ono Pharmaceutical Co Ltd - Major Products and Services 8
Ono Pharmaceutical Co Ltd - History 10
Ono Pharmaceutical Co Ltd - Company Statement 16
Ono Pharmaceutical Co Ltd - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 19
Ono Pharmaceutical Co Ltd - Business Description 19
Ono Pharmaceutical Co Ltd - SWOT Analysis 20
SWOT Analysis - Overview 20
Ono Pharmaceutical Co Ltd - Strengths 20
Ono Pharmaceutical Co Ltd - Weaknesses 21
Ono Pharmaceutical Co Ltd - Opportunities 22
Ono Pharmaceutical Co Ltd - Threats 23
Ono Pharmaceutical Co Ltd - Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios - Interim Ratios 30
Financial Ratios - Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 33
Ono Pharmaceutical Co Ltd, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
Dec 21, 2016: ONO PHARMACEUTICAL: Revisions of Consolidated Financial Forecasts 35
Oct 19, 2016: Merus Receives Milestone Payment from Ono Pharmaceutical for Selection of Bispecific Antibody Candidate for Clinical Development and Extends Partnership with CMC Service Agreement 36
Jul 27, 2016: Infusion of Nearly $35.4 Million in Grant Funding to Support Roswell Park Research 37
Mar 01, 2016: Completion of the new Research Building (The Third Building) in the Minase Research Institute 39
Jan 26, 2016: ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Tables
Ono Pharmaceutical Co Ltd, Key Facts 5
Ono Pharmaceutical Co Ltd, Key Employees 6
Ono Pharmaceutical Co Ltd, Key Employee Biographies 7
Ono Pharmaceutical Co Ltd, Major Products and Services 8
Ono Pharmaceutical Co Ltd, History 10
Ono Pharmaceutical Co Ltd, Other Locations 17
Ono Pharmaceutical Co Ltd, Subsidiaries 17
Ono Pharmaceutical Co Ltd, Key Competitors 24
Ono Pharmaceutical Co Ltd, Ratios based on current share price 25
Ono Pharmaceutical Co Ltd, Annual Ratios 26
Ono Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 27
Ono Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 28
Ono Pharmaceutical Co Ltd, Interim Ratios 30
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 33
Ono Pharmaceutical Co Ltd, Recent Deals Summary 34
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44
List of Figures
Ono Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 29
Ono Pharmaceutical Co Ltd, Ratio Charts 31
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 33

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report